Aparna Ahuja Net Worth & Insider Trades
Aparna Ahuja - Chief Medical Officer, T2 Biosystems, Inc
What is Aparna Ahuja's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Chief Medical Officer, Aparna Ahuja, is estimated to be about $124.64K . Aparna Ahuja owns about 107,611 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, Aparna Ahuja has sold an estimated value of $29.75K worth.
What is Aparna Ahuja's Past Insider Trading?
Aparna Ahuja's largest sale order was 61,988 units , worth over $29.75K on January 10, 2022. In total, Aparna Ahuja has made about 4 transactions over a year of their time at T2 Biosystems, Inc. Aparna Ahuja usually trades in January, with the busiest year in 2022.
Aparna Ahuja
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Aparna Ahuja's' Mailing Address?
- Mailing address is 101 Hartwell Avenue Lexington MA 02421 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on April 6, 2023 by Terrence Michael Gibbs who sold 239 units worth $114.96 . In the last 9 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.1M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, Terrence Michael Gibbs, General Counsel, and David Elsbree, Director .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||